Cargando…
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
Flaviviruses cause a significant amount of mortality and morbidity, especially in regions where they are endemic. A recent example is the outbreak of Zika virus throughout the world. Development of antiviral drugs against different viral targets is as important as the development of vaccines. During...
Autores principales: | Samrat, Subodh K., Xu, Jimin, Li, Zhong, Zhou, Jia, Li, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955721/ https://www.ncbi.nlm.nih.gov/pubmed/35335617 http://dx.doi.org/10.3390/pathogens11030293 |
Ejemplares similares
-
Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022) -
NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus
por: Natarajan, Satheesh
Publicado: (2010) -
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
por: Samrat, Subodh Kumar, et al.
Publicado: (2020) -
Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses
por: Eyer, Luděk, et al.
Publicado: (2018) -
Cycluridine: A novel antiviral effective against flaviviruses
por: Galabov, Angel S, et al.
Publicado: (2017)